Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Standard Capecitabine in Advanced Breast Cancer
NCT00418028Phase 3Completed
- Sponsor
- Hospital Clínico San Carlos
- Start
- Sep 2005
- Primary completion
- Dec 2011
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in breast cancer, sponsored by Hospital Clínico San Carlos. Started Sep 2005; status: completed.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00418028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418028.